Back to GetFilings.com



 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 10-Q

 

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2003

 

o

 

TRANSITION PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the transition period from             to             

 

 

 

 

 

Commission File Number: 1-12624

 

 

 

Syratech Corporation

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

13-3354944

(State or other jurisdiction
of incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

 

 

175 McClellan Highway
East Boston, Massachusetts

 

02128-9114

(Address of  principal executive office)

 

(Zip Code)

 

 

 

Registrant’s telephone number, including area code - 617-561-2200

 

Indicate by check mark whether the registrant:  (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES   o   NO   ý

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act.)    YES   o   NO   ý

 

Number of Shares of Common Stock, Par Value $0.01 per share, outstanding at March 31, 2003 - 3,784,018

 

 


 


 

INDEX

 

PART I - FINANCIAL INFORMATION

 

Item 1.

Financial Statements:

 

 

 

Condensed Consolidated Balance Sheets at March 31, 2003 and December 31, 2002

 

 

 

Condensed Consolidated Income Statements of Operations for the three month periods ended March 31, 2003 and 2002

 

 

 

Condensed Consolidated Statements of Cash Flows for the three month periods ended March 31, 2003 and 2002

 

 

 

Notes to Condensed Consolidated Financial Statements

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

Item 4.

Controls and Procedures

 

 

PART II - OTHER INFORMATION

 

Item 6.

Exhibits and Reports on Form 8-K

 

 

 

Signature

 



 

SYRATECH CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)

 

 

 

March 31,
2003

 

December 31,
2002

 

ASSETS

 

(Unaudited)

 

 

 

Current assets:

 

 

 

 

 

Cash and equivalents 

 

$

853

 

$

1,399

 

Accounts receivable, net

 

26,274

 

51,582

 

Inventories 

 

60,213

 

58,198

 

Deferred income taxes.

 

13,167

 

20,649

 

Prepaid expenses and other

 

3,056

 

2,627

 

Assets held for sale 

 

 

3,395

 

Total current assets

 

103,563

 

137,850

 

 

 

 

 

 

 

Property, plant and equipment, net

 

38,492

 

59,742

 

Other assets, net

 

3,893

 

5,154

 

Total

 

$

145,948

 

$

202,746

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Revolving loan facilities and notes payable 

 

$

3,945

 

$

23,383

 

Accounts payable

 

8,099

 

8,107

 

Accrued expenses

 

8,993

 

11,887

 

Accrued interest

 

6,148

 

3,586

 

Accrued compensation

 

2,242

 

3,529

 

Accrued advertising

 

2,967

 

3,945

 

Deferred gain

 

1,546

 

 

Income taxes payable

 

234

 

32

 

Liabilities held for sale 

 

 

645

 

Total current liabilities 

 

34,174

 

55,114

 

 

 

 

 

 

 

Long - term debt 

 

119,500

 

153,584

 

Deferred income taxes 

 

8,434

 

15,434

 

Pension liability 

 

2,743

 

2,674

 

Long-term deferred gain

 

4,121

 

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $.01 par value, 500,000 shares authorized; (25,000 designated as cumulative redeemable preferred stock, 18,000 shares issued and outstanding, liquidation value of $18,000, and includes accrued and unpaid dividends of $17,451 and $16,419 in 2003 and 2002, respectively)

 

35,451

 

34,419

 

Common stock, $.01 par value, 20,000,000 shares authorized; 3,784,018  shares issued and outstanding 

 

38

 

38

 

Deficit

 

(58,200

)

(58,392

)

Accumulated other comprehensive loss

 

(313

)

(125

)

Total stockholders’ equity 

 

(23,024

)

(24,060

)

Total

 

$

145,948

 

$

202,746

 

 

See notes to consolidated financial statements.

 

1



 

SYRATECH CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(in thousands, except per share data)

 

 

 

Three Months
Ended March 31,

 

 

 

2003

 

2002

 

 

 

 

 

 

 

Net sales

 

$

40,673

 

$

38,251

 

Cost of sales

 

29,808

 

27,340

 

 

 

 

 

 

 

Gross profit

 

10,865

 

10,911

 

 

 

 

 

 

 

Selling, general and administrative expenses 

 

13,510

 

15,146

 

 

 

 

 

 

 

Operating income (loss) from continuing operations 

 

(2,645

(4,235

)

 

 

 

 

 

 

Interest expense 

 

(4,239

)

(4,911

)

 

 

 

 

 

 

Gain on extinguishment of debt

 

9,040

 

1,236

 

 

 

 

 

 

 

Interest income 

 

1

 

 

 

 

 

 

 

 

Income (loss) from continuing operations before provision (benefit) for income taxes 

 

2,157

 

(7,910

)

 

 

 

 

 

 

Provision (benefit) for income taxes 

 

880

 

(1,812

)

 

 

 

 

 

 

Income (loss) from continuing operations before cumulative effect of a change in accounting principle

 

1,277

 

(6,098

)

 

 

 

 

 

 

Discontinued Operations:

 

 

 

 

 

 

 

 

 

 

 

Loss from operations of discontinued subsidiaries

 

(53

)

(129

)

 

 

 

 

 

 

Income (loss) before cumulative effect of a change in accounting principle

 

1,224

 

(6,227

)